CYP 5.26% 20.0¢ cynata therapeutics limited

Ann: DFU Clinical Trial Enrolment Complete, page-7

  1. 7,601 Posts.
    lightbulb Created with Sketch. 6870
    Yep. If you've been following the changes at the FDA an accelerated approval definitely a possibility in this one. The FDA is to its credit trying to improve the laboured process of its approvals in novel biologics for chronic illnesses where patients face a very poor prognosis under standard of care. Far too mnay amputations globally for DFU. This one is crying for out an AA.


 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
20.0¢
Change
0.010(5.26%)
Mkt cap ! $36.13M
Open High Low Value Volume
20.5¢ 20.5¢ 20.0¢ $8.749K 42.75K

Buyers (Bids)

No. Vol. Price($)
2 19130 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 20000 1
View Market Depth
Last trade - 13.09pm 06/09/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.